Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed or Refractory B-cell Lymphomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT03571568
What this trial is testing

BI-1206 in Combination With Rituximab With or Without Acalabrutinib in Subjects With Indolent B-Cell NHL

Who this might be right for
Indolent B-Cell Non-Hodgkin Lymphoma
BioInvent International AB 140
Early research (Phase 1)UnknownNCT03881774
What this trial is testing

Cord Blood Derived CAR-T Cells in Refractory/Relapsed B Cell Malignancies

Who this might be right for
RefractoryRelapsedB Cell Lymphoma+1 more
Henan Cancer Hospital 20
Testing effectiveness (Phase 2)Ended earlyNCT00005950
What this trial is testing

506U78 in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or T-cell Lymphoma

Who this might be right for
Angioimmunoblastic T-cell LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell Lymphoma+7 more
National Cancer Institute (NCI) 111
Testing effectiveness (Phase 2)UnknownNCT04431089
What this trial is testing

Efficacy and Safety of SHC014748M in Patients With Relapsed or Refractory Follicular (FL) or Marginal Zone (MZL) Lymphoma

Who this might be right for
Follicular Lymphoma(FL)Marginal Zone Lymphoma(MZL)
Nanjing Sanhome Pharmaceutical, Co., Ltd. 122
Testing effectiveness (Phase 2)Study completedNCT03458260
What this trial is testing

Study of Pixantrone in CD20+ Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma

Who this might be right for
Aggressive Non-Hodgkin Lymphoma
The Lymphoma Academic Research Organisation 74
Large-scale testing (Phase 3)Active Not RecruitingNCT06929624
What this trial is testing

Clinical Study of SHR-A1912 Combined With R-GemOx Versus R-GemOx in Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 282
Early research (Phase 1)UnknownNCT04887025
What this trial is testing

Exploratory Study of a Novel Oncolytic Vaccinia Virus RGV004 in the Treatment of Refractory/Relapsed B-cell Lymphoma

Who this might be right for
Relapsed or Refractory B-cell Lymphoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 25
Large-scale testing (Phase 3)Study completedNCT00005805
What this trial is testing

St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer

Who this might be right for
Chronic Myeloproliferative DisordersFatigueLeukemia+5 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT01649622
What this trial is testing

Bendamustine in Acute Lymphoblastic Leukemia/Lymphoma (ALL)

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00873457
What this trial is testing

Perifosine in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Daphne Friedman 16
Early research (Phase 1)Looking for participantsNCT06703892
What this trial is testing

Evaluate the Safety and Clinical Activity of GF- CART01 (CD20/19 CAR T Cell) in Subjects With Relapsed or Refractory B-Cell Hematological Malignancies

Who this might be right for
Diffuse Large B Cell Lymphoma RelapsedDiffuse Large B Cell Lymphoma RefractoryFollicular Lymphoma ( FL)+3 more
GenomeFrontier Therapeutics TW Co., Ltd. 18
Testing effectiveness (Phase 2)Looking for participantsNCT05147467
What this trial is testing

Study of APG-2575 in Patients With Relapsed/Refractory CLL/SLL

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Ascentage Pharma Group Inc. 75
Testing effectiveness (Phase 2)Looking for participantsNCT06996132
What this trial is testing

Bispecific Antibody-Based Salvage Therapy Followed by CAR-T ± ASCT in R/R Aggressive B-Cell Lymphoma

Who this might be right for
Relapsed or Refractory Aggressive B-cell Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 25
Early research (Phase 1)WithdrawnNCT00730652
What this trial is testing

Study of MDX-1411 in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma

Who this might be right for
Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma.
Bristol-Myers Squibb 34
Testing effectiveness (Phase 2)Looking for participantsNCT06987916
What this trial is testing

Efficacy and Safety Evaluation of U01(ssCART-19) in B-Cell Lymphoma

Who this might be right for
B Cell Lymphoma
Shanghai Tongji Hospital, Tongji University School of Medicine 50
Testing effectiveness (Phase 2)Ended earlyNCT05360238
What this trial is testing

Study to Assess Safety, Tolerability and Efficacy of MB-106 in Patients With Relapsed or Refractory B-Cell NHL or CLL

Who this might be right for
Follicular B-cell Non-Hodgkin's LymphomaMantle Cell Lymphoma RecurrentMantle Cell Lymphoma Refractory+5 more
Mustang Bio 20
Testing effectiveness (Phase 2)Looking for participantsNCT06985485
What this trial is testing

Full-Course Immunotherapy Consolidation for Unfit or Fit B-ALL Who Decline Chemotherapy

Who this might be right for
Acute Lymphoblastic LeukemiaImmunotherapyBlinatumomab+1 more
The First Affiliated Hospital of Soochow University 26
Early research (Phase 1)Study completedNCT05364424
What this trial is testing

A Study Evaluating the Efficacy, Safety, and Pharmacokinetics of Glofitamab in Combination With Rituximab Plus Ifosfamide, Carboplatin Etoposide Phosphate in Participants With Relapsed/Refractory Transplant or CAR-T Therapy Eligible Diffuse B-Cell Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma (DLBCL)
Hoffmann-La Roche 43
Testing effectiveness (Phase 2)Study completedNCT02423291
What this trial is testing

SGN-35 (Brentuximab Vedotin) of Patients With Relapsed or Refractory PMLBCL

Who this might be right for
Primary Mediastinal Large B Cell Lymphoma
Fondazione Italiana Linfomi - ETS 15
Early research (Phase 1)Study completedNCT00509691
What this trial is testing

Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy

Who this might be right for
Cancer
University of Louisville 20
Next Page